Skip to content

NovoCure NVCR United States — Net revenues

Other geography segments

Germany
$21.33M
France
$20.29M
Japan
$10.21M
Greater China
$4.64M

Similar metrics at other companies

FIGS logo
FIGSUnited States — Net revenues
$131.59M+24.1%
Haemonetics logo
HAEUnited States — Net revenues
$251.97M+1.5%
Enphase Energy logo
ENPHUnited States — Net revenues
$233.91M-11.1%
Sotera Health logo
SHCUnited States — Total net revenues
$157.39M+2.1%
Baxter International logo
BAXUnited States — Net Sales
$1.44B-3.7%
Globus Medical logo
GMEDUnited States — Net Sales
$604.89M+25.0%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.64B-36.7%
Enterprise value$1.59B-36.3%
P/S2.4×-1.7×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's united states — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's united states — net revenues?
NovoCure (NVCR) reported united states — net revenues of $95.96M in Q1 2026.
How has NovoCure's united states — net revenues changed year-over-year?
NovoCure's united states — net revenues increased by 3.0% year-over-year, from $93.15M to $95.96M.
What is the long-term trend for NovoCure's united states — net revenues?
Over 4 years (2021 to 2025), NovoCure's united states — net revenues has grown at a 2.2% compound annual growth rate (CAGR), from $353.11M to $385.63M.
What does united states — net revenues mean?
This metric represents the total revenue generated from the sale of medical devices and associated services within the United States geographic market after accounting for returns, discounts, and allowances. It serves as a primary indicator of the company's commercial penetration and market demand for its therapeutic technologies within this specific region. Tracking this figure helps investors evaluate the effectiveness of regional sales strategies and the adoption rate of the company's product portfolio.